Keeping its bladder clean, dry and mold-free between uses! That's where the DRYE device comes in, as it's a battery-powered fan designed specifically to dry hydration pack bladders. SUBSCRIBE ...

A urinary tract infection (UTI) can occur in different parts of the urinary tract, such as the bladder or kidneys. It is the result of bacteria entering the urinary tract through the penis.

Mark D. Tyson, MD, MPH, discusses cretostimogene and how it varies from other therapies for bladder cancer. Cretostimogene grenadenorepvec is an investigational oncolytic immunotherapy that is being ...

Early findings from Johnson & Johnson’s Phase IIb SunRISe-1 trial show the promise of TAR-200 in patients with Bacillus Calmette-Guérin–unresponsive, high-risk non–muscle-invasive bladder cancer, ...

“Complication rates were super low: just 3.7% for prostate surgeries, 1.9% for kidney surgeries, and 17.9% for bladder surgeries, all beating safety goals from years of research”. The company further ...

Pfizer has linked its PD-1 inhibitor to a 32% reduction in the risk of disease-related events in a phase 3 bladder cancer trial. But the study fell short of a clean sweep of positive outcomes ...

TAR-200 demonstrated high DFS and bladder preservation rates in BCG-unresponsive, high-risk non-muscle-invasive bladder cancer with papillary-only disease. The phase 2b SunRISe-1 study showed over 80% ...

Pfizer has shared the trial results with worldwide regulatory bodies in preparation for filing regulatory applications. Credit: © 2025 Pfizer. US-based ...

Pfizer’s sasanlimab, when used with standard of care, reduced the likelihood of disease recurrence or progression, death due to any cause or persistence of cancer cells by 32% in patients with ...

US pharma major Pfizer (NYSE: PFE) reported new Phase III data over the weekend showing that its investigational PD-1 inhibitor sasanlimab, delivered subcutaneously, significantly improved outcomes ...

With an FDA review underway, Johnson & Johnson is aiming to “fundamentally change” how bladder cancer is treated. That’s how Biljana Naumovic, president of J&J’s U.S. solid tumor business ...

LAS VEGAS -- Patients with high-risk, treatment-unresponsive non-muscle invasive bladder cancer (NMIBC) had an unprecedented response rate and disease-free survival (DFS) with an investigational ...